BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Lumentum Holdings Inc. (Nasdaq – LITE), Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC)

Brodsky & Smith said it is reminding investors of unspecified investigations and invited shareholders to contact the firm to discuss them at no cost or financial obligation. The excerpt names no companies, allegations, investigation details, or financial figures.

Analysis

This is a solicitation notice, not evidence of a filed complaint, regulatory finding, or established liability. It identifies no companies, conduct, transaction, or affected securities, so there is no defensible issuer-level earnings, valuation, or portfolio-exposure inference. Treat any market impact as unquantifiable and likely negligible absent follow-up naming targets; do not generalize legal risk across a sector. The key near-term check is whether the firm or another source identifies an issuer and provides verifiable allegations or a filing. Over the next 1–3 months, reassess only if a complaint, merger challenge, or company disclosure creates a concrete catalyst. A formal filing or material company response would change the evidence base; a continued generic investigation notice would not. No trade is warranted on this item alone.

Key Decisions for Investors

• Do not initiate a long, short, or options position based solely on this notice; no target securities are identified.
• Monitor for a named issuer, the alleged conduct and relevant period, and confirmation of an actual court filing or regulatory action before assessing exposure.
• If an issuer is later named, evaluate the specific claim, transaction status, potential damages or remedy, and the issuer’s response; distinguish an investigation from an adjudicated finding.